Hexachlorophene, a selective SHP2 inhibitor, suppresses proliferation and metastasis of KRAS-mutant NSCLC cells by inhibiting RAS/MEK/ERK and PI3K/AKT signaling pathways
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Toxicology
Reference62 articles.
1. SHP2 drives adaptive resistance to ERK signaling inhibition in molecularly defined subsets of ERK-dependent tumors;Ahmed;Cell Rep.,2019
2. Beta4 integrin activates a Shp2-Src signaling pathway that sustains HGF-induced anchorage-independent growth;Bertotti;J. Cell Biol.,2006
3. Mitochondria, bioenergetics and apoptosis in cancer;Burke;Trends Cancer,2017
4. Targeting protein tyrosine phosphatase SHP2 for therapeutic intervention;Butterworth;Future Med. Chem.,2014
5. The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity;Canon;Nature,2019
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. CD74–ROS1 L2026M mutant enhances autophagy through the MEK/ERK pathway to promote invasion, metastasis and crizotinib resistance in non‐small cell lung cancer cells;The FEBS Journal;2024-01-12
2. Asperuloside regulates the proliferation, apoptosis, and differentiation of chronic myeloid leukemia cell line K562 through the RAS/MEK/ERK pathway;Heliyon;2024-01
3. MEK/ERK and PI3K/AKT pathway inhibitors affect the transformation of myelodysplastic syndrome into acute myeloid leukemia via H3K27me3 methylases and de‑methylases;International Journal of Oncology;2023-11-03
4. Reversible and irreversible inhibitors of coronavirus Nsp15 endoribonuclease;Journal of Biological Chemistry;2023-11
5. Study on Exploration Potential Anti-Cancer Activity miRNAs and Its Expression Rule Related to Growth Years in Mountain-Cultivated Ginseng;Russian Journal of Plant Physiology;2023-05-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3